TY  - CONF 
AU  - Antón Aparicio, Luis Miguel
PY  - 2015
SN  - 1743-7555
UR  - http://hdl.handle.net/20.500.11940/3467
LA  - eng
TI  - Real-world use of cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) PREVIOUSLY TREATED WITH DOCETAXEL: REGIONAL ANALYSIS
VL  - 11
ER  -